The Rare Diseases Clinical Research Network’s Developmental Synaptopathies Consortium (DSC) has named Felix Chan, PhD, as the winner of its first-ever TSC Alliance Young Investigator Award for research in tuberous sclerosis complex.
Brown University’s Felix Chan Wins Young Investigator Award from Developmental Synaptopathies Consortium
Rare Disease Research Training Program
September 2015 was the launch of The Rare Disease Research Training Program with our first in-person 2 day meeting.
The training program, supported by an RDCRN R25 grant, is a 12 month series of in-person and webinar-based opportunities allowing for synchronous and asynchronous learning opportunities to better understand the practical skills required to succeed in rare disease clinical research.
The goals of the program are to:
Early Stage Investigator Spotlight: Siddharth Srivastava Investigates Genetic Causes of Neurodevelopmental Disorders
Siddharth Srivastava, MD, is a pediatric neurologist at Boston Children's Hospital specializing in neurogenetics. He is also a member of the Developmental Synaptopathies Consortium (DSC). Dr. Srivastava’s research focuses on neurodevelopmental phenotyping and biomarker discovery in Phelan-McDermid syndrome (PMS), tuberous sclerosis complex (TSC), and PTEN hamartoma tumor syndrome (PHTS). Here, he shares his start in rare disease research, exciting discoveries, and future goals.
DSC Announces First-Ever PTEN Research Young Investigator Award
The Developmental Synaptopathies Consortium (DSC) and PTEN Research Foundation announce the selection of their first-ever Young Investigator Award for PTEN hamartoma tumor syndrome (PHTS) research, Andrew Dhawan, MD, DPhil, a resident physician in the Department of Neurology at Cleveland Clinic.
Training Program for Clinical Research in Rare Disease Launches New Session
The National Institutes of Health-funded R25 Rare Disease Clinical Research Training Program is launching a new training program for clinical research in rare disease. Now in its seventh year, this year-long, hybrid, free program is designed to support new investigators in the field of rare disease clinical research.
Pre-Doc Preparatory Program (P³) in Translational Research
Do you have a rare disease research coordinator, genetic counseling assistant, or technician who may benefit from formal training in clinical and translational research? If so, we invite you to nominate them for the one-year Pre-Doc Preparatory Program (P³) in Translational Research from October 2025 through May 2026, offered by ITMAT Education at the University of Pennsylvania in partnership with the CHOP Leukodystrophy Center.